|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improving stem cell mobilization strategies: future directions 显示文摘 | Bensinger W DiPersio JF McCarty JM | 2009 | Bone MarrowTransplant2009，43，3： | 1 |
| 2 | A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies显示文摘 | Rizzieri D A Feldman E DiPersio J F | 2008 | Clin Cancer Res2008，14，9： | 1 |
| 3 | Conditional enhancement of liver-specific gene transcription显示文摘 | Zaret KS DiPersio CM Jackson SA | 1988 | Proc Nail Acad Sci USA1988，85，： | 1 |
| 4 | Self- complementary oligopeptide matrices support mammalian cell attachment显示文摘 | Zhang S Holmes T C Dipersio C M | 1995 | Biomaterials1995，16，： | 1 |
| 5 | lntegrin alphaVbeta3 binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor 显示文摘 | Garrigues HJ Rubinchikova YE Dipersio CM | 2008 | J Virol2008，82，3： | 1 |
| 6 | Phase III prospec tive randomized double-blind placebo-controlled trial of plerixafor plus granuloeyte colony- stimulating factor compared with placebo plus granulocyte colony-stimula- ting factor for autologous stem-cell mobilization and transplantation for patients With non-Hodgkins lymphoma显示文摘 | DiPersio JF Mieallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 7 | Update on clinical experience with amda100,an sdf-1/cxc1l2-cxcr4 inhibitor,in mobilization of hematopoietic stem and progenitor cells显示文摘 | Pusic I DiPersio JF | 2010 | Curr Opin Hematol2010，17，4： | 1 |
| 8 | α3β1 integrin is reguired for normal development of the epidermal basement membrane显示文摘 | Dipersio CM Hodivala-Dike R Jaenisch JA | 1997 | J Cell Bio11997，137，： | 1 |
| 9 | Alpha 3betal integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression 显示文摘 | IYER V PUMIGLIA K DIPERSIO C M | 2005 | J Cell Sci2005，118，6： | 1 |
| 10 | Plerix- afor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem transplanta- tion in patients with multiple myetoma显示文摘 | DiPersio JF Stadtmauer EA Nademanee A | 2009 | Blood2009，113，23： | 1 |
| 11 | Novel strategies for hematopoietic stem cell mobilization 显示文摘 | Devine SM Link D DiPersio JF | 2004 | Current Opinion in Organ Transplantation2004，9，1： | 1 |
| 12 | Granulocyte - macro- phage colony - stimulating factor induces human melanoma - cell migration 显示文摘 | Kohn EC Hollister GH DiPersio JD | 1993 | Int J Cancer1993，53，6： | 1 |
| 13 | A Phase Ⅲ , multicenter, randomized, double- blind, placebo controlled, comparative trial of AMD3100 (plerixafor) + G-CSF vs placebo + G-CSF in non- Hodgkin's-lymphoma (NHL) patients for autologous hematopoieticstem cell (aHSC) transplantation 显示文摘 | DiPersio JF | 2007 | ASH Annual Meeting Abs2007，110，： | 1 |
| 14 | Evolution and dissemination of extended - spectrum beta - lactamase- producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program ( 1997 - 2003 ) 显示文摘 | DiPersio JR Deshpande LM Biedenbach DJ | 2005 | Diagn Microbiol Infect Dis2005，51，1： | 1 |
| 15 | A phase Ⅲ , multicenter, randomized, double- blind, placebo controlled, comparative trial of AMD3100 (Plerixafor) + G-CSF vs G-CSF + placebo for mobilization in multiple myeloma (MM) patients for autologous hematopoieticstem cell (aHSC) transplantation 显示文摘 | DiPersio JF | 2007 | ASH Annual Meeting Abs2007，110，： | 1 |
| 16 | Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation显示文摘 | Graubert TA DiPersio JF Russell JH | 1997 | J Clin Invest1997，100，4： | 1 |
| 17 | Approaching and analyzing a large literature on vancomycin monitoring andpharmacokinetics显示文摘 | Lee P DiPersio D Jerome RN | 2007 | J Med Libr Assoc2007，95，4： | 1 |
| 18 | Alpha3 betal integfin regulates MMP-9 mRNA stability in immortalized keratinocytes:a novel mechanism of integrin-mediated MMP gene expression显示文摘 | Iyer V Pumiglia K DiPersio CM | 2005 | J Cell Sci2005，118，6： | 1 |
| 19 | A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies 显示文摘 | RIZZIERI DA FELDMAN E DIPERSIO JF | 2008 | Clin Cancer Res2008，14，9： | 1 |
| 20 | Update on clinical experience with AMD3100,an SDF-1/CXCL12-CXCR4 inhibitor,in mobilization of hematopoietic stem and progenitor cells显示文摘 | Pusic I DiPersio JF | 2010 | Curr Opin Hematol2010，17，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员